Publicaciones (63) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. Against All Odds? Addiction History Associated with Better Viral Hepatitis Care: A Dutch Nationwide Claims Data Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Beneficios de una intervención conjunta con la familia de mujeres con cáncer de mama antes de la cirugía

    Metas de enfermería, Vol. 25, Núm. 4, pp. 22-31

  3. Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  4. Effect of Obesity and Roux-En-Y Gastric Surgery on Omeprazole Pharmacokinetics

    Obesity Facts, Vol. 15, Núm. 2, pp. 271-280

  5. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

    The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340

  6. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

  7. Immune Response and Reactogenicity After Immunization With a Suboptimal Two-Dose mRNA Vaccine Followed by a Full Vaccination With a Standard mRNA Vaccine Compared to a Prime-Boost Regimen of a Standard mRNA Vaccine: A Multicenter Cohort Study

    SSRN Electronic Journal

  8. Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

    eClinicalMedicine, Vol. 51

  9. Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS Study

    SSRN Electronic Journal

  10. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

  11. Immunological safety assessment of a single and repeated intra-articular administration of xenogeneic equine umbilical cord mesenchymal stem cells under field conditions in young healthy dogs: A randomized double-blind placebo-controlled study

    Research in Veterinary Science and Medicine, Vol. 2, pp. 2

  12. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

    The Lancet, Vol. 399, Núm. 10339, pp. 1941-1953